Table 4.
n | events | 3-year survival rate (%) | hazard ratio | 95% CI | p | |
---|---|---|---|---|---|---|
biology-based tumor type | 105 | 27 | < 0.0001a | |||
HR+/HER2- | 56 | 8 | 96.3 | 1.00 | ||
HR+/HER2+ | 13 | 2 | 90.0 | 1.26 | 0.27-5.98 | 0.770 |
HR-/HER2+ | 12 | 8 | 33.3 | 9.32 | 3.45-25.13 | < 0.0001 |
HR-/HER2- | 24 | 9 | 65.0 | 2.23 | 1.24-8.40 | 0.016 |
Ki67 | 96 | 21 | ||||
<= 20% | 79 | 16 | 87.7 | 1.00 | ||
> 20% | 17 | 5 | 70.6 | 1.43 | 0.52-3.94 | 0.486 |
pCR | 105 | 27 | ||||
no pCR | 95 | 26 | 80.0 | 1.00 | ||
pCR | 10 | 1 | 90.0 | 0.29 | 0.04-2.15 | 0.227 |
ypN | 105 | 27 | ||||
ypN0 | 65 | 13 | 83.1 | 1.00 | ||
ypN1-2 | 40 | 14 | 52.4 | 2.46 | 1.142-5.302 | 0.021 |
CI: confidence interval.
a: overall significance.